Mark Kiel, MD, PhD

Company: Genomenon
Job title: Chief Scientific Officer
Part of the World CNS Series: Neurodegenerative Drug Development Summit | Neuroimmunology Drug Development Summit | Neuromuscular Drug Development Summit | Neuropsychiatry Drug Development Summit | Blood-Brain Barrier Summit | Biomarkers for Alzheimer’s Disease Summit
Company: Genomenon
Job title: Chief Scientific Officer